Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Antigen 85 complex protein A is one of three major secreted proteins (Ag85A, Ag85B, Ag85C) produced by *Mycobacterium tuberculosis* and related mycobacteria. It functions as a mycolyltransferase, catalyzing the transfer of mycolic acids in the synthesis of trehalose dimycolate, a key glycolipid essential for the integrity and pathogenicity of the mycobacterial cell wall[1][2][3][10]. Ag85A is highly immunogenic and participates in interactions with host extracellular matrix (binds fibronectin)[5][6][9][10]. Because of its essential function in cell wall assembly and its accessible location as a secreted protein, Ag85A is a validated drug target for novel tuberculosis treatments and a major antigen in vaccine development and diagnostic assays[3][4][8].
Covalent allosteric inhibition of mycolyltransferase activity through modification of a cysteine residue near the active site (e.g., by ebselen)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antigen 85 complex protein A (Ag85A).